Vanguard Global Advisers’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.78M Sell
20,384
-1,229
-6% -$151K ﹤0.01% 1058
2026
Q1
$2.55M Buy
+21,613
New +$3.02M ﹤0.01% 1039

Other funds holding RGEN

Vanguard Global Advisers's RGEN Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Repligen (RGEN) stake by 5.7% in Q2 2026, selling an estimated $151K and leaving 20,384 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1058.

Vanguard Global Advisers first reported a position in RGEN in Q1 2026 and has held it in 2 quarters since. 472 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Vanguard Global Advisers held 20,384 shares of Repligen worth $2.78M as of Q2 2026.
  • Vanguard Global Advisers sold 1,229 Repligen shares in Q2 2026, an estimated $151K.
  • Repligen made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1058 holding.
  • Vanguard Global Advisers first reported a position in Repligen in Q1 2026 and has held it in 2 quarters since.
  • 472 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.